0001891244-22-000001.txt : 20220127 0001891244-22-000001.hdr.sgml : 20220127 20220127155049 ACCESSION NUMBER: 0001891244-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220127 DATE AS OF CHANGE: 20220127 EFFECTIVENESS DATE: 20220127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Insightful Science Holdings, LLC CENTRAL INDEX KEY: 0001891244 IRS NUMBER: 823694359 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-431102 FILM NUMBER: 22563048 BUSINESS ADDRESS: STREET 1: 2365 NORTHSIDE DRIVE, SUITE 560 CITY: SAN DIEGO STATE: CA ZIP: 92108 BUSINESS PHONE: 310-927-5629 MAIL ADDRESS: STREET 1: 2365 NORTHSIDE DRIVE, SUITE 560 CITY: SAN DIEGO STATE: CA ZIP: 92108 D 1 primary_doc.xml X0708 D LIVE 0001891244 Insightful Science Holdings, LLC 2365 NORTHSIDE DRIVE, SUITE 560 SAN DIEGO CA CALIFORNIA 92108 310-927-5629 DELAWARE GraphPad Holdings, LLC Insightful Science, LLC None Limited Liability Company true 2017 Peter Segall 2365 Northside Drive, Suite 560 San Diego CA CALIFORNIA 92108 Director Jeff Lieberman 2365 Northside Drive, Suite 560 San Diego CA CALIFORNIA 92108 Director Paige Searle 2365 Northside Drive, Suite 560 San Diego CA CALIFORNIA 92108 Director Karen De Castro 2365 Northside Drive, Suite 560 San Diego CA CALIFORNIA 92108 Director Thomas Swalla 2365 Northside Drive, Suite 560 San Diego CA CALIFORNIA 92108 Executive Officer Director Chief Executive Officer Rebeca Sanchez Sarmiento 2365 Northside Drive, Suite 560 San Diego CA CALIFORNIA 92108 Executive Officer Chief Financial Officer Katherine McSweeny 2365 Northside Drive, Suite 560 San Diego CA CALIFORNIA 92108 Executive Officer Global Controller Other Decline to Disclose 06b false 2021-10-14 true true true Profits Interest Units false 0 Indefinite 66281251 Indefinite The Total Amount Sold above is the per-unit amount that would need to be distributed to existing equity holders before the securities in this offering would be eligible to receive any distributions. (See item 15 clarification below). false 3 0 0 The securities are intended to qualify as profits interests for U.S. tax purposes and entitle recipients to a pro rata portion of the appreciation in the Issuer's value above the value on the date of grant, (continued in item 16 clarification below) 0 (continued from item 15 clarification above) and have no value for U.S. tax purposes on the grant date. The date of the first sale in item 7 above is the date of the first grant in this Rule 506(b) offering. false Insightful Science Holdings, LLC Rebeca Sanchez Sarmiento Rebeca Sanchez Sarmiento See explanation box in item 3. 2022-01-27